NEW YORK, Dec. 8 Reportlinker.com announces that a new market research report is available in its catalogue:
Cardiac Biomarkers - A Global Market Perspective
Advertisement
http://www.reportlinker.com/p0164258/Cardiac-Biomarkers---A-Global-Market-Perspective.html
Rising cases of cardiovascular diseases and ageing population have served as primary growth drivers for cardiac biomarkers market, a key sector in the clinical immunodiagnostics market. The global healthcare sector places utmost importance on fast and accurate identification of heart problems, in order to initiate timely and accurate treatment at the earliest. Cardiac biomarkers help in detecting the severity and existence of heart problems at the earliest. The Point-of-Care Testing (POCT) platform is more popular among the new breed of physicians who give prime importance on faster results and mobility; while experienced physicians rely more on Laboratory Testing platform that is perceived to be more accurate and provide detailed analysis.
Advertisement
These and other market data and trends are presented in "Cardiac Biomarkers: A Global Market Perspective" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
CARDIAC BIOMARKERS BMR-1058
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. INDUSTRY OVERVIEW 4
Cardiovascular Diseases: Leading Cause of Mortality Worldwide 4
Basic Topologies of Cardiovascular Diseases 5
Fast and Accurate Diagnosis - Reduce Unnecessary Healthcare Costs 5
Cardiac Biomarkers - Making Diagnosis Easier and Quicker 6
What is a Cardiac Marker: 6
Necessity of a Cardiac Marker Assay Test 6
Major Cardiac Markers and their Properties 7
Market Outlook 8
Market Trends 8
Strong Demand for Risk Assessment Markers 8
Intense Competition among Players in the Cardiac Diagnostics
Market 8
The Future of Cardiac Marker POCT Segment 8
Need for Early Detection Markers 9
Rapid Turnaround time: A Crucial Parameter for POC Testing Kits 9
3. COMPETITIVE ANALYSIS 10
Siemens Healthcare becomes the leader, after a series of
Acquisitions 10
Product Portfolio of Bayer and Dade Behring 11
4. CARDIAC MARKERS AND MYOCARDIAL INFARCTION 12
Chain Reaction After an Event of MI 12
Action Plan after an Event of MI 12
Protocol for Conducting AMI Markers Tests 13
Creatine Kinase - The Traditional Gold Standard, Loosing Sheen 13
Isomers 13
Kinetics 14
Purpose of Test and When to Order 14
Cardiac Troponin - Taking Over from CK-MB 14
Overview 14
Troponin Tissue-Specific Subtypes 14
Other Diseases 15
Uses of Troponin Tests 15
New Advanced High-sensitivity (Hs) Cardiac Troponin Tests 15
Myoglobin 16
Purpose of Test and When to Order 16
5. CARDIAC MARKERS AND CONGESTIVE HEART FAILURE (CHF) 16
Key Facts 17
BNP (B-type Natriuretic Peptide) 17
NT-proBNP (N-terminal proBNP) 18
Purpose of Tests and When to Order 18
Market Characteristics 18
Choosing the Right BNP and NT proBNP Assay Kit in the Market 20
Evolution of BNP and NT proBNP Market 20
NT-proBNP is superior to BNP in Predicting Mortality in Heart
Failure Patients, with Reduced Kidney Function 21
6. STROKE BIOMARKERS - A REVIEW 21
Player Initiatives 22
Other Important Cardiac Biomarkers 22
Homocysteine 22
C-Reactive Protein 23
Plasminogen Activator Inhibitor-1 24
D-Dimer 24
Thrombus Precursor Protein 24
Potential Future Cardiac Biomarkers 24
7. CARDIAC BIOMARKER TESTING IN CLINICAL LABORATORIES 27
Leading Players in Laboratory Cardiac Markers 27
8. CARDIAC BIOMARKERS AT POINT-OF- CARE TESTING 28
Major Players Operating in the Cardiac Markers POCT Segment 28
Cardiac Markers Point-of-Care testing (POCT) Segment: Major
Players & Their Operating Brands 29
9. CORPORATE DEVELOPMENTS 30
Response Biomedical Signs Partnership Agreement with Roche 30
Nanogen and Elitech Plans to Merge 30
Compugen Announces Discovery of Troponin I Biomarker Variant,
Inks Agreement with Biosite 30
Response Bags FDA Clearance for RAMP® NT-proBNP Test 31
Inverness Acquires Biosite 31
Siemens Acquires Diagnostic Division of Bayer Healthcare 31
Siemens Announces Acquisition of Dade Behring 31
Beckman Collaborates in CVD Related Research Projects 32
Dade Behring Receives Sublicense to New Cardiac Marker 32
Inverness Acquires Cholestech 32
Response Biomedical Secures Clearance to Market RAMP® NT-
proBNP Test 33
Acrongenomics Collaborates with Molecular Vision and Pearson
Matthews 33
BG Medicine Obtains Rights to Develop Tests for Congestive
Heart Failure 33
Nanogen Gains US Reissue Patent for Combined Use of Biomarkers
for CHF Diagnosis 34
bioMerieux Rolls out VIDAS® NT-proBNP 34
Roche Diagnostics Introduces Cobas-H-232 Handheld Cardiac
Marker System 34
XIS Discovers a Unique Diagnostic Biomarker for Cardiovascular
Disease 35
Ortho-Clinical Presents Sensitivity Troponin I Test, VITROS
Troponin I ES 35
10. MAJOR PLAYERS 36
Abbott Diagnostics (USA) 36
Ani Biotech Oy (Finland) 36
Axis-Shield PoC (UK) 36
Beckman Coulter, Inc. (USA) 36
biomerieux (France) 37
Inverness Medical Innovations, Inc. (USA) 37
LifeSign LLC (USA) 37
Nanogen Inc. (USA) 37
Ortho-Clinical Diagnostics, Inc. (USA) 37
Oxis International, Inc. (USA) 38
Prognostix, Inc. (USA) 38
Response Biomedical Corp. (Canada) 38
Roche Diagnostics Corp. (USA) 39
Siemens Healthcare Diagnostics, Inc. (USA) 39
11. GLOBAL MARKET ANALYTICS 40
12. THE UNITED STATES 47
Cardiovascular Diseases in the US: A Review 47
30% Fall in Number of Deaths due to Heart Diseases & Strokes
Over Last Decade 47
Senior Citizens at High Risk for Heart Failure 48
CHF Biomarkers to Spearhead the US market 48
US Cardiac Markers POCT Segment 48
13. EUROPE 52
a. France 57
b. Germany 58
c. Italy 59
d. The United Kingdom 60
e. Rest of Europe 62
14. REST OF WORLD 63
Evolution of BNP Test market in Japan 63
Table 1: Region-Wise Incidence and Prevalence of
Cardiovascular Diseases in 2006
EXHIBITS
Table 2: Global Cardiac Biomarkers Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 3: Percentage Breakdown of Global Cardiac Biomarkers
Market by Region for the Years 2009 & 2012
Table 4: Global Cardiac Biomarkers Market in Laboratory
Testing Sector by Region for the Period 2007-2015 (Sales in
US$ Million)
Table 5: Percentage Breakdown of Global Cardiac Biomarkers
Market in Laboratory Testing Sector by Region for the Years
2009 & 2012
Table 6: Global Cardiac Biomarkers Market in Point-of-Care
Testing Sector by Region for the Period 2007-2015 (Sales in
US$ Million)
Table 7: Percentage Breakdown of Global Cardiac Biomarkers
Market in Point-of-Care Testing Sector by Region for the Years
2009 & 2012
Table 8: Global CK-MB Assay Test Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 9: Percentage Breakdown of Global CK-MB Assay Test
Market by Region for the Years 2009 & 2012
Table 10: Global Cardiac Troponin Assay Test Market by Region
for the Period 2007-2015 (Sales in US$ Million)
Table 11: Percentage Breakdown of Global Cardiac Troponin
Assay Test Market by Region for the Years 2009 & 2012
Table 12: Global Myoglobin Assay Test Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 13: Percentage Breakdown of Global Myoglobin Assay Test
Market by Region for the Years 2009 & 2012
Table 14: Global BNP & NT pro-BNP Assay Test Market by Region
for the Period 2007-2015 (Sales in US$ Million)
Table 15: Percentage Breakdown of Global BNP & NT pro-BNP
Assay Test Market by Region for the Years 2009 & 2012
Table 16: Market Shares of Leading AMI (Acute Myocardial
Infarction) Diagnostics Manufacturer Revenues in the US - 2006
Table 17: Market Shares of Leading CHF (Congestive Heart
Failure) Diagnostics Manufacturer Revenues in the US - 2006
Table 18: Market Shares of Leading Manufacturers in the
Laboratory Testing Segment in the US - 2001
Table 19: Cardiac Biomarkers Market by Segment in the US:
2007-2015 (Sales in US$ Million)
Table 20: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in the US for the Years 2009 & 2012
Table 21: Cardiac Biomarkers Market by Test Type in the US:
2007-2015 (Sales in US$ Million)
Table 22: Percentage Breakdown of Cardiac Biomarkers Market by
Test Type in the US for the Years 2009 & 2012
Table 23: Cardiac Biomarkers Market by Region in Europe:
2007-2015 (Sales in US$ Million)
Table 24: Percentage Breakdown of Cardiac Biomarkers Market by
Region in Europe for the Years 2009 & 2012
Table 25: Cardiac Biomarkers Market by Segment in Europe:
2007-2015 (Sales in US$ Million)
Table 26: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in Europe for the Years 2009 & 2012
Table 27: Cardiac Biomarkers Market by Assay Test Type in
Europe: 2007-2015 (Sales in US$ Million)
Table 28: Percentage Breakdown of Cardiac Biomarkers Market by
Assay Test Type in Europe for the Years 2009 & 2012
Table 29: Cardiac Biomarkers Market by Segment in France:
2007-2015 (Sales in US$ Million)
Table 30: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in France for the Years 2009 & 2012
Table 31: Cardiac Biomarkers Market by Segment in Germany:
2007-2015 (Sales in US$ Million)
Table 32: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in Germany for the Years 2009 & 2012
Table 33: Cardiac Biomarkers Market by Segment in Italy:
2007-2015 (Sales in US$ Million)
Table 34: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in Italy for the Years 2009 & 2012
Table 35: Cardiac Biomarkers Market by Segment in the UK:
2007-2015 (Sales in US$ Million)
Table 36: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in the UK for the Years 2009 & 2012
Table 37: Cardiac Biomarkers Market by Segment in Rest of
Europe: 2007-2015 (Sales in US$ Million)
Table 38: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in Rest of Europe for the Years 2009 & 2012
Table 39: Cardiac Biomarkers Market by Segment in Rest of
World: 2007-2015 (Sales in US$ Million)
Table 40: Percentage Breakdown of Cardiac Biomarkers Market by
Segment in Rest of World for the Years 2009 & 2012
Table 41: Cardiac Biomarkers Market by Assay Test Type in Rest
of World: 2007-2015 (Sales in US$ Million)
Table 42: Percentage Breakdown of Cardiac Biomarkers Market by
Assay Test Type in Rest of World for the Years 2009 & 2012
COMPANIES PROFILED
To order this report:
Cardiovascular Devices Industry: Cardiac Biomarkers - A Global Market Perspective
More Market Research Report
Nicolas BombourgReportlinkerEmail: [email protected]: (805)652-2626Intl: +1 805-652-2626
SOURCE Reportlinker
